J.P. Cassuto

1.2k total citations
34 papers, 751 citations indexed

About

J.P. Cassuto is a scholar working on Genetics, Epidemiology and Hematology. According to data from OpenAlex, J.P. Cassuto has authored 34 papers receiving a total of 751 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 8 papers in Epidemiology and 6 papers in Hematology. Recurrent topics in J.P. Cassuto's work include Chronic Lymphocytic Leukemia Research (7 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Pneumocystis jirovecii pneumonia detection and treatment (3 papers). J.P. Cassuto is often cited by papers focused on Chronic Lymphocytic Leukemia Research (7 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Pneumocystis jirovecii pneumonia detection and treatment (3 papers). J.P. Cassuto collaborates with scholars based in France, United Kingdom and Germany. J.P. Cassuto's co-authors include Bruno Spire, J.A. Gastaut, J. Moreau, J. P. Moatti, Patrizia Carrieri, Marcel Deckert, P Jeandel, Michel Ticchioni, Sophie Raynaud and Patrick Auberger and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Oncogene.

In The Last Decade

J.P. Cassuto

34 papers receiving 719 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.P. Cassuto France 12 258 211 187 161 149 34 751
M J Cowan United States 11 182 0.7× 105 0.5× 231 1.2× 97 0.6× 173 1.2× 13 822
Shigehisa Mori Japan 13 247 1.0× 71 0.3× 123 0.7× 84 0.5× 82 0.6× 40 625
J.A. Gastaut France 16 239 0.9× 251 1.2× 149 0.8× 127 0.8× 514 3.4× 38 1.1k
Abhay Patki United States 11 138 0.5× 129 0.6× 234 1.3× 307 1.9× 235 1.6× 18 729
R Cuthbert United Kingdom 14 81 0.3× 126 0.6× 72 0.4× 112 0.7× 196 1.3× 40 607
Fabrice Monpoux France 12 127 0.5× 311 1.5× 179 1.0× 217 1.3× 311 2.1× 44 931
J. A. Gastaut France 18 202 0.8× 199 0.9× 75 0.4× 127 0.8× 336 2.3× 40 937
Seymour Fein United States 17 207 0.8× 78 0.4× 95 0.5× 67 0.4× 37 0.2× 40 1.0k
J Maciejewski United States 11 336 1.3× 65 0.3× 93 0.5× 105 0.7× 370 2.5× 23 852
Charikleia Kelaïdi France 14 80 0.3× 108 0.5× 197 1.1× 292 1.8× 457 3.1× 45 742

Countries citing papers authored by J.P. Cassuto

Since Specialization
Citations

This map shows the geographic impact of J.P. Cassuto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.P. Cassuto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.P. Cassuto more than expected).

Fields of papers citing papers by J.P. Cassuto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.P. Cassuto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.P. Cassuto. The network helps show where J.P. Cassuto may publish in the future.

Co-authorship network of co-authors of J.P. Cassuto

This figure shows the co-authorship network connecting the top 25 collaborators of J.P. Cassuto. A scholar is included among the top collaborators of J.P. Cassuto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.P. Cassuto. J.P. Cassuto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cluzeau, Thomas, Chimène Moreilhon, Nicolas Mounier, et al.. (2013). Total genomic alteration as measured by SNP-array-based molecular karyotyping is predictive of overall survival in a cohort of MDS or AML patients treated with azacitidine. Blood Cancer Journal. 3(11). e155–e155. 14 indexed citations
2.
Gamas, Pascal, Sandrine Marchetti, Alexandre Puissant, et al.. (2009). Inhibition of imatinib-mediated apoptosis by the caspase-cleaved form of the tyrosine kinase Lyn in chronic myelogenous leukemia cells. Leukemia. 23(8). 1500–1506. 20 indexed citations
3.
Puissant, Alexandre, Pascal Colosetti, Guillaume Robert, et al.. (2009). Cathepsin B release after imatinib-mediated lysosomal membrane permeabilization triggers BCR–ABL cleavage and elimination of chronic myelogenous leukemia cells. Leukemia. 24(1). 115–124. 38 indexed citations
4.
Baudot, Alice D., P Jeandel, Xavier Mouska, et al.. (2009). The tyrosine kinase Syk regulates the survival of chronic lymphocytic leukemia B cells through PKCδ and proteasome-dependent regulation of Mcl-1 expression. Oncogene. 28(37). 3261–3273. 92 indexed citations
5.
Ticchioni, Michel, Makram Essafi, P Jeandel, et al.. (2007). Homeostatic chemokines increase survival of B-chronic lymphocytic leukemia cells through inactivation of transcription factor FOXO3a. Oncogene. 26(50). 7081–7091. 80 indexed citations
6.
Jacquel, Arnaud, Magali Herrant, Virginie Defamie, et al.. (2005). A survey of the signaling pathways involved in megakaryocytic differentiation of the human K562 leukemia cell line by molecular and c-DNA array analysis. Oncogene. 25(5). 781–794. 68 indexed citations
7.
Moatti, J. P., Patrizia Carrieri, Bruno Spire, et al.. (2000). Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment. AIDS. 14(2). 151–155. 201 indexed citations
8.
Rosenthal, Éric, Pierre Marty, Y. Le Fichoux, & J.P. Cassuto. (2000). Clinical manifestations of visceral leishmaniasis associated with HIV infection: a retrospective study of 91 French cases. Annals of Tropical Medicine and Parasitology. 94(1). 37–42. 11 indexed citations
9.
Delaney, Stephen, et al.. (1994). Prevalence of antibody to hepatitis C virus (HCV) in HIV‐1‐infected patients (nice seroco cohort). Journal of Medical Virology. 42(1). 29–32. 57 indexed citations
10.
Cassuto, J.P., et al.. (1993). [Evaluation of the activities and value of allergo-anesthetic consultation at the University Hospital Center of Nice 1985-1991].. PubMed. 47(5). 423–7. 2 indexed citations
11.
Taillan, B, C. Roul, Jean‐Gabriel Fuzibet, et al.. (1989). Circulating anticoagulant in patients seropositive for human immunodeficiency virus. The American Journal of Medicine. 87(2). 238–238. 11 indexed citations
12.
Vinti, H, et al.. (1989). Accidents systémiques des bêta-bloquants en collyres: A propos de six observations. La Revue de Médecine Interne. 10(1). 41–44. 2 indexed citations
13.
Vinti, H, et al.. (1989). Accidents systémiques des bêta-bloquants en collyres. La Revue de Médecine Interne. 10(1). 41–44. 4 indexed citations
14.
Squara, Pierre, Jean‐Michel Verdier, P Lapalus, et al.. (1982). [Candida albicans spondylitis. Review of the literature apropos of a case with study of bone penetration of 5-fluorocytosine].. PubMed. 133(6). 410–5. 3 indexed citations
15.
16.
Joyner, M V, et al.. (1978). Long remission after lymphoblastic transformation of chronic granulocytic leukaemia.. BMJ. 1(6126). 1525.1–1525. 5 indexed citations
17.
Joyner, M V, et al.. (1977). Hypercalcaemia as complication of accelerated chronic granulocytic leukaemia.. BMJ. 2(6094). 1060.1–1060. 8 indexed citations
18.
Cassuto, J.P., et al.. (1977). Acute infectious lymphocytosis as a T-cell lymphoproliferative syndrome.. BMJ. 2(6098). 1331.2–1332. 5 indexed citations
19.
Masseyeff, R, et al.. (1974). Alpha-Fetoprotein Radioimmunoassay in Blood Diseases. New England Journal of Medicine. 291(10). 532–532. 1 indexed citations
20.
Cassuto, J.P.. (1971). Maladie de Biermer.. 108(12). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M J Cowan Breakdown of academic impact, for papers by Shigehisa Mori Breakdown of academic impact, for papers by J.A. Gastaut Breakdown of academic impact, for papers by Abhay Patki Breakdown of academic impact, for papers by R Cuthbert Breakdown of academic impact, for papers by Fabrice Monpoux Breakdown of academic impact, for papers by J. A. Gastaut Breakdown of academic impact, for papers by Seymour Fein Breakdown of academic impact, for papers by J Maciejewski Breakdown of academic impact, for papers by Charikleia Kelaïdi
Rankless by CCL
2026